Diagnostics of invasive meningococcal, haemophilus and pneumococcal disease by PCR assay;Diagnostika invazivního meningokokového, hemofilové ho a pneumokokového onemocněni PCR metodou

Klinicka Mikrobiologie a Infekcni Lekarstvi

Volumn 10, Issue 3, 2004, Pages 130-133

  Kalmusová, Jitka ^a   Bronska E ^a   Krizova P ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; POLYMERASE CHAIN REACTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; HAEMOPHILUS; INFANT; MULTILOCUS SEQUENCE TYPING; SENSITIVITY AND SPECIFICITY;

BACTERIAL DNA;

DNA, BACTERIAL; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE;

EID: 3543098690     PISSN: 1211264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Albrich WC, Angstwurm M, Bader L, et al. Drug resistance in intensive care units. Infection 1999;27,Suppl 2:19-23.
2. Catchpole CR, Andrews JM, Brenwald N, et al. A reassessment of the in vitro activity of colistin sulphomethate sodium. J Antimicrob Chemother 1997;39:255-260.
3. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and Western Pacific Region for the SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 2001;32,Suppl 2:114-132.
4. Evans ME, Feola DJ, Rapp RP. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother 1999; 33:960-967.
5. Flournoy DJ, Reinert RL, Bell-Dixon C, et al. Increasing antimicrobial resistance in gram-negative bacilli isolated from patients in intensive care units. Am J Infect Control 2000;28:244-250.
6. Gales AC, Jones NR, Turnige J, et al. Characterisation of Pseudomonas aeruginosa isolates: occurence, rates, antimicrobial susceptibility paterns, and molecular typing in the global SENTRY antimicrobial srveillance program, 1997-1999. Clin Infect Dis 2001a;32, Suppl 2:146-155
7. Gales AC, Jones RN, Forward KR, et al. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997-1999). Clin Infect Dis 2001b;32,Suppl 2:104-113.
8. Gattringer R, Nikš M, Ostertág R, et al. Evaluation of MIDITECH automated colorimetric MIC reading for antimicrobial susceptibility testing. J Antimicrob Chemother 2002;49:651-659.
9. Hamer DH. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 2000;162:328-33.
10. Kohler T, Pechere JC, Plesiat P. Bacterial antibiotic efflux systems of medical importance. Cell Mol Life Sci 1999, 56:771-778.
11. Levin AS, Barone AA, Penco J, et al. Intravenous colistin as therapy for nosocomial infections caused by multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999;28:1008-1011.
12. Livermore DM.: Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother 2001;47:247-250.
13. Livermore DM, Winstanley TG, Shannon KP. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother 2001;48,Suppl 1:87-102.
14. Low DE, Keller N, Barth A, et al. Clinical prevalence, antimicrobial susceptibility and geografic resistance paterns of Enterococci: results from the SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 2001;32,Suppl 2:133-145.
15. MacGowan AP, Wise R. Estabilishing MIC breakpoints and the interpretation of in vitro susceptibility tests. J Antimicrob Chemother 2001;48,Suppl 1:17-28.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement. NCCLS document M2-A7 and M7-A5, Vol. 22, No. 1. NCCLS, Wayne, Pa 2002.
17. Quinn, JP. Clinical problems posed by multiresistant nonfermenring gram-negative pathogens. Clin Infect Dis 1998;27,Suppl 1:117-124.
18. Reese RE, Betts RF, Gumustop B. Handbook of antibiotics. 3rd ed. Philadelphia: Lippincott Williams & Willkins 2000:441-444.
19. Simon C., Stille W. Antibiotika v současné lékařské praxi. Praha, Grada 1998:711.
20. Tsiodras S, Pittet D, Carmeli Y, et al. Clinical implications of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals. Scand J Infect Dis 2000,32:651-656.
21. Van den Waaij D. Colonisation resistance of the digestive tract: clinical consequences and implications. J Antimicrob Chemother 1982,10: 263-270.